Related Experiment Video
Updated: Jul 25, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Brain-tumour drug resistance: the bare essentials
1Department of General Neurosurgery, Neurocenter, University of Freiburg, Freiburg, Germany. bredel@nz.ukl.uni-freiburg.de
The Lancet. Oncology
|July 27, 2002
Summary
Chemotherapy is often ineffective against primary brain tumors due to drug resistance. Understanding molecular markers associated with this resistance is crucial for developing better treatments for brain cancer patients.
Area of Science:
- Oncology
- Neuro-oncology
- Molecular Biology
Background:
- Chemotherapy demonstrates limited efficacy in most primary human brain tumors.
- Treatment outcomes for patients with brain cancers remain largely unimproved by chemotherapy.
- Tumor-cell resistance is the primary reason for the unsatisfactory results of chemotherapeutic interventions.
Purpose of the Study:
- To review molecular markers associated with chemoresistance in brain tumors.
- To summarize key factors contributing to a chemoresistant phenotype.
- To highlight the need for understanding resistance mechanisms for future therapeutic strategies.
Main Methods:
- Literature review of studies on primary human brain tumors.
- Analysis of molecular markers linked to chemoresistance.
- Synthesis of information on cellular mechanisms of drug resistance.
Main Results:
- Several molecular markers, not exclusive to brain tumors, are associated with chemoresistance.
- These markers contribute to the development of a chemoresistant phenotype in brain tumor cells.
- The review identifies key factors implicated in the regulation of chemoresistance.
Conclusions:
- Elucidating cellular mechanisms of resistance is essential for advancing brain cancer treatment.
- Future progress requires targeted modulation of drug resistance in brain lesions.
- Developing more effective chemotherapeutic approaches necessitates a deeper understanding of resistance pathways.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...